Microbot Medical (MBOT) Invested Capital (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Invested Capital data on file, last reported at $74.1 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 155.97% year-over-year to $74.1 million; the trailing twelve-month figure through Mar 2026 stood at $74.1 million (up 155.97% YoY), and the FY2025 full-year result was $77.6 million, up 2097.0% from the prior year.
• Invested Capital for Q1 2026 stood at $74.1 million, down from $77.6 million in the prior quarter.
• Across five years, Invested Capital topped out at $78.2 million in Q3 2025 and bottomed at $3.5 million in Q4 2024.
• The 5-year median for Invested Capital is $7.4 million (2023), against an average of $21.6 million.
• The widest annual swing landed in 2022, when Invested Capital plunged 69.04%; it then surged 2097.0% in 2025.
• A 5-year view of Invested Capital shows it stood at $7.3 million in 2022, then tumbled by 38.25% to $4.5 million in 2023, then retreated by 21.57% to $3.5 million in 2024, then soared by 2097.0% to $77.6 million in 2025, then fell by 4.45% to $74.1 million in 2026.
• The last three Invested Capital figures came in at $74.1 million (Q1 2026), $77.6 million (Q4 2025), and $78.2 million (Q3 2025), per Business Quant data.

Peer Comparison